Drug Trial Radar · NCT04650542
Drug-Drug Interaction Study of HBI-3000 and Paroxetine in Healthy Adult Male and Female Subjects
Last checked: Nov 20, 2026Latest source record: Jul 15, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
39
Actual
Start
Feb 21, 2021
Primary completion
Aug 13, 2021
Study completion Aug 13, 2021
Sponsor
- Lead sponsor
- HUYABIO International, LLC.Industry
- Sponsor type
- Industry
- First posted
- Dec 2, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 50 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Drug-Drug Interaction Study of HBI-3000 and Paroxetine in Healthy Adult Male and Female Subjects
Conditions
- Drug-drug Interaction
Interventions
HBI-3000Drug
small molecule, multi-ion channel blocker
ParoxetineDrug
serotonin uptake inhibitor, CYP2D6 inhibitor
Primary outcomes
What the sponsor says the trial is designed to measure.
- Plasma pharmacokinetics (PK): Maximum observed plasma concentration (Cmax)Time frame: 72 hours
- Plasma pharmacokinetics (PK): Area Under the Curve (AUC) from time 0 to last measurable concentration (AUC0 - tau)Time frame: 72 hours
- Plasma pharmacokinetics (PK): Area Under the Curve (AUC) from time 0 to infinity (AUC0 - infinity), if data permitsTime frame: 72 hours
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
Spaulding Clinical
West Bend, Wisconsin
Nucleus Network Pty Ltd.
Melbourne, Victoria, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.